BioNeMo Early Access

BioNeMo Framework and Cloud Service are now available for early access.

At GTC Fall 2022, NVIDIA introduced BioNeMo, an AI-powered drug discovery large language model framework for training and deploying large biomolecular transformer AI models at supercomputing scale.

Shortly after GTC, we opened the BioNeMo framework for running on your own infrastructure to a select group of customers. Now, we are opening both the BioNeMo framework and cloud service for early access by application.

To apply for access, please fill out the questionnaire using the link below. You will be prompted to join the NVIDIA developer program and the entire process should take roughly 5 minutes.

Apply Now. .